Long-term outcome of resuming anticoagulation after anticoagulation-associated intracerebral hemorrhage
Introduction: The risk and benefit of restarting oral anticoagulation (OAC) therapy among patients with atrial fibrillation or flutter (AF) and an episode of anticoagulation-associated intracerebral hemorrhage (ICH) remain unclear. Whether or not to resume OAC after an OAC-associated ICH will remain...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | eNeurologicalSci |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405650220300010 |